Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis
Background. Patients with advanced gastric cancer (AGC) with peritoneal carcinomatosis (PC) usually have poor outcomes and high mortality risk, even with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). This study analyzed the prognostic factors of AGC with PC and e...
Guardado en:
Autores principales: | Ting-Ying Lee, Guo-Shiou Liao, Hsiu-Lung Fan, Chung-Bao Hsieh, Teng-Wei Chen, De-Chuan Chan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9bef4de70b3428e904e7ab25a4cd7c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
por: Thomas Boerner, et al.
Publicado: (2021) -
Imaging of Gastric Carcinomatosis
por: Raquel Saiz Martínez, et al.
Publicado: (2021) -
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group’s analysis
por: Luigina Graziosi, et al.
Publicado: (2021) -
The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
por: Siyuan Qian, et al.
Publicado: (2021) -
Implementation of the enhanced
recovery after surgery protocol for patients with peritoneal
carcinomatosis undergoing cytoreductive surgery and
hyperthermic intraperitoneal chemoperfusion
por: Oleksandr Ivanovych Tkachenko, et al.
Publicado: (2021)